Difference between revisions of "Team:Manchester-Graz/Attributions"
m |
Martin2801 (Talk | contribs) |
||
Line 31: | Line 31: | ||
<h1>Attributions</h1> | <h1>Attributions</h1> | ||
+ | <br><br> | ||
− | + | <h2>General Support</h2> | |
− | <h2> | + | |
<ul> | <ul> | ||
− | + | <li>Prof. Dr. Anton Glieder: Supervision of Team Graz, organizational work</li> | |
− | + | <li>Prof. Dr. Christoph Sensen: general support regarding organizational work and social media</li> | |
− | + | <li>Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work</li> | |
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | + | ||
− | <li>Prof Dr Anton Glieder: Supervision of | + | |
− | <li>Prof Dr Christoph Sensen: general support regarding organizational work and social media</li> | + | |
− | <li>Dr Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work</li> | + | |
<li>Christian Schmid: helped us with organization and shipment of products from our sponsors</li> | <li>Christian Schmid: helped us with organization and shipment of products from our sponsors</li> | ||
− | <li>Dr Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process</li> | + | <li>Dr. Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process</li> |
− | <li>Prof Dr Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision</li> | + | <li>Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision</li> |
− | <li>Prof Dr | + | <li>Prof Dr. Reiner Breitling: modeling advisor, supervision</li> |
− | <li>Prof Dr Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer </li> | + | <li>Prof Dr. Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer </li> |
<li>Lorna Hepworth: supervision, new techniques explanation </li> | <li>Lorna Hepworth: supervision, new techniques explanation </li> | ||
<li>Alexander Wood: supervision, lab help, HPLC expert</li> | <li>Alexander Wood: supervision, lab help, HPLC expert</li> | ||
<li>Nicholas Weise: supervision, lab help , HPLC expert</li> | <li>Nicholas Weise: supervision, lab help , HPLC expert</li> | ||
<li>Robert Harrison: supervision, HP explanation, help in contacting </li> | <li>Robert Harrison: supervision, HP explanation, help in contacting </li> | ||
+ | <li>Dr. Peter Both</li> | ||
+ | <li>Adrian Jarvis</li> | ||
+ | <li>Sandra Taylor</li> | ||
+ | <li>Rehana</li> | ||
+ | <li>Dr Neil Swainston</li> | ||
</ul> | </ul> | ||
Line 63: | Line 59: | ||
<h2>Human Practices </h2> | <h2>Human Practices </h2> | ||
<ul> | <ul> | ||
− | <li>Prof Dr Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> | + | <li>Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background</li> |
<li>Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser | <li>Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser | ||
Modeling Support</li> | Modeling Support</li> | ||
− | <li>Dr Monty Silverdale: interview form a practicing doctor and opinions on our project</li> | + | <li>Dr. Monty Silverdale: interview form a practicing doctor and opinions on our project</li> |
− | <li>Prof Dr Angela Tod: interview </li> | + | <li>Prof Dr. Angela Tod: interview </li> |
<li>Julia: PD patient interview with shedding light on PD and our project from a patient’s point of view </li> | <li>Julia: PD patient interview with shedding light on PD and our project from a patient’s point of view </li> | ||
− | <li>Dr Andy Balmer: | + | <li>Dr Andy Balmer: HP explanation </li> |
</ul> | </ul> | ||
Line 80: | Line 76: | ||
</ul> | </ul> | ||
+ | <br><br> | ||
+ | <h2>Special Thank You to our sponsors!</h2> | ||
+ | |||
+ | <ul> | ||
+ | <li>University of Technology Graz</li> | ||
+ | <li>The University of Manchester</li> | ||
+ | <li>Sanofiy</li> | ||
+ | <li>Evolva</li> | ||
+ | <li>IBCarb Network</li> | ||
+ | <li>Integrated DNA Technologies</li> | ||
+ | <li>Bartelt</li> | ||
+ | <li>Lactan</li> | ||
+ | <li>Microsynth</li> | ||
+ | <li>Qiagen</li> | ||
+ | <li>New England BioLabs Inc.</li> | ||
+ | <li>ThermoFisher Scientific</li> | ||
+ | <li>VWR International</li> | ||
+ | <li>Ardeypharm</li> | ||
+ | <li>SnapGene</li> | ||
+ | <li>Sigma-Aldrich</li> | ||
+ | <li>Promega</li> | ||
+ | <li>SMB Industrieanlagenbau GmbH</li> | ||
+ | <li>Merck Millipore</li> | ||
+ | |||
</div> | </div> | ||
+ | <div style="height:50px; width:900px;"></div> | ||
<div id="footer"> | <div id="footer"> |
Revision as of 16:23, 4 September 2015
Attributions
General Support
- Prof. Dr. Anton Glieder: Supervision of Team Graz, organizational work
- Prof. Dr. Christoph Sensen: general support regarding organizational work and social media
- Dr. Martina Geier: supported us during the whole iGEM process not only with the organization of our team but also during our lab work
- Christian Schmid: helped us with organization and shipment of products from our sponsors
- Dr. Birgit Wiltschi: helped us with our Vector Design and gave general support during the vector assembly process
- Prof Dr. Eriko Takano: UoM iGEM organizer, Supervisor and primary team contact, supervision
- Prof Dr. Reiner Breitling: modeling advisor, supervision
- Prof Dr. Sabine Flitsch: supervision, inter-European team idea organizer, gut bacteria idea, PD patient interview organizer
- Lorna Hepworth: supervision, new techniques explanation
- Alexander Wood: supervision, lab help, HPLC expert
- Nicholas Weise: supervision, lab help , HPLC expert
- Robert Harrison: supervision, HP explanation, help in contacting
- Dr. Peter Both
- Adrian Jarvis
- Sandra Taylor
- Rehana
- Dr Neil Swainston
Human Practices
- Prof. Dr. Reidl: Discussion about human gut bacteria composition, feasibility of our project idea, general background knowledge exchange, ethic background
- Dr. Christoph Högenauer: Discussion about treatment of Parkinson patients, feasibility and possible application of the DopaDoser Modeling Support
- Dr. Monty Silverdale: interview form a practicing doctor and opinions on our project
- Prof Dr. Angela Tod: interview
- Julia: PD patient interview with shedding light on PD and our project from a patient’s point of view
- Dr Andy Balmer: HP explanation
Modeling
- Areti Tsigkinopoulou: Supported the model developing process of a quorum sensing system, general Matlab and Simbiology support
- Dr Neil Swainston: introducing MatLab, explaining Flux Balance Analysis modeling and guiding us throughout the project on modeling
Special Thank You to our sponsors!
- University of Technology Graz
- The University of Manchester
- Sanofiy
- Evolva
- IBCarb Network
- Integrated DNA Technologies
- Bartelt
- Lactan
- Microsynth
- Qiagen
- New England BioLabs Inc.
- ThermoFisher Scientific
- VWR International
- Ardeypharm
- SnapGene
- Sigma-Aldrich
- Promega
- SMB Industrieanlagenbau GmbH
- Merck Millipore